Correlation between main clinicohistologic features and overall FOXP3-positive Treg number in diagnostic samples
Variable . | No. . | FOXP3 less than 10, % . | FOXP3 more than 10, % . | P . |
---|---|---|---|---|
Histologic grade | ||||
1 | 24 | 50 | 50 | .057 |
2 | 57 | 46 | 54 | |
3 (a + b) | 16 | 75 | 25 | |
Histologic pattern | ||||
Follicular | 83 | 49 | 51 | >.1 |
Follicular and diffuse | 5 | 83 | 17 | |
Diffuse | 9 | 56 | 44 | |
Ann Arbor stage | ||||
I to III | 32 | 63 | 37 | >.1 |
IV | 58 | 48 | 52 | |
Serum LDH | ||||
Normal | 67 | 48 | 52 | >.1 |
High | 20 | 70 | 30 | |
Serum β2m | ||||
Normal | 45 | 53 | 47 | >.1 |
High | 28 | 57 | 43 | |
FLIPI | ||||
Low risk | 32 | 53 | 47 | .007 |
Intermediate risk | 23 | 30 | 70 | |
High risk | 31 | 74 | 36 |
Variable . | No. . | FOXP3 less than 10, % . | FOXP3 more than 10, % . | P . |
---|---|---|---|---|
Histologic grade | ||||
1 | 24 | 50 | 50 | .057 |
2 | 57 | 46 | 54 | |
3 (a + b) | 16 | 75 | 25 | |
Histologic pattern | ||||
Follicular | 83 | 49 | 51 | >.1 |
Follicular and diffuse | 5 | 83 | 17 | |
Diffuse | 9 | 56 | 44 | |
Ann Arbor stage | ||||
I to III | 32 | 63 | 37 | >.1 |
IV | 58 | 48 | 52 | |
Serum LDH | ||||
Normal | 67 | 48 | 52 | >.1 |
High | 20 | 70 | 30 | |
Serum β2m | ||||
Normal | 45 | 53 | 47 | >.1 |
High | 28 | 57 | 43 | |
FLIPI | ||||
Low risk | 32 | 53 | 47 | .007 |
Intermediate risk | 23 | 30 | 70 | |
High risk | 31 | 74 | 36 |